Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Analysts

Key Points

• Analysts have an average “Hold” rating on Teladoc Health, with 10 holds, five buys and one sell among 16 firms. The average 12-month price target is $7.54, modestly above the reported $6.32 share price.
• Teladoc’s latest quarterly results showed an adjusted loss of $0.21 per share, better than the expected $0.25 loss, but revenue of $606.9 million missed estimates and declined 4% year over year.
• The company remains unprofitable, with a negative net margin and return on equity, while institutional investors own approximately 76.8% of its shares. CEO Charles III also sold shares to cover tax-withholding obligations.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been given an average recommendation of "Hold" by the sixteen research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $7.5357.

TDOC has been the topic of several research reports. Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Citigroup reduced their price objective on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Bank of America increased their price target on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a "buy" rating in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group lowered their target price on Teladoc Health from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, July 30th.

Teladoc Health Price Performance

Teladoc Health stock opened at $6.32 on Friday. The stock has a market capitalization of $1.15 billion, a price-to-earnings ratio of -6.38 and a beta of 2.12. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.89. The business has a fifty day moving average price of $7.23 and a 200-day moving average price of $6.80.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same period in the prior year, the company posted ($0.19) EPS. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. On average, equities research analysts anticipate that Teladoc Health will post -0.92 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, CEO Charles III sold 17,805 shares of the company's stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $6.10, for a total value of $108,610.50. Following the completion of the transaction, the chief executive officer owned 465,535 shares in the company, valued at approximately $2,839,763.50. This represents a 3.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company's stock.

Institutional Trading of Teladoc Health

A number of institutional investors and hedge funds have recently made changes to their positions in TDOC. Monaco Asset Management SAM purchased a new position in shares of Teladoc Health during the 2nd quarter worth $26,864,000. ABS Investment Management LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $1,513,154. Jupiter Asset Management Ltd. grew its holdings in shares of Teladoc Health by 293.9% in the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider's stock valued at $27,021,000 after purchasing an additional 2,880,008 shares during the period. Nano Cap New Millennium Growth Fund L P acquired a new stake in Teladoc Health during the fourth quarter worth about $1,225,000. Finally, Pale Fire Capital SE raised its stake in Teladoc Health by 74.8% during the first quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider's stock worth $18,522,000 after purchasing an additional 1,454,288 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company's offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.